Polymorphism of angiotensin-converting enzyme gene and BMI in obese Korean women

Clinica Chimica Acta

Volumn 328, Issue 1-2, 2003, Pages 173-178

  Um, Jae Young ^a,b   Mun, Kyong Suk ^a   An, Nyeon Hyoung ^a   Kim, Pil Geun ^a   Kim, Sang Don ^c   Song, Yung Sun ^c   Lee, Ki Nam ^c   Lee, Kang Min ^b   Wi, Dae Han ^d   You, Yong Ouk ^a   Kim, Hyung Min ^a  

^a Wonkwang University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Wonkwang University   (South Korea)

^d Wonkwang University School of Medicine   (South Korea)

Author keywords

Angiotensin converting enzyme gene; Body mass index; Koreans; Obese women; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADOLESCENT; ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; KOREA; NORMAL HUMAN; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0037306346     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00428-X     Document Type: Article

References (32)

1. Reid I.A., Morris B.J., Ganong W.F. The renin-angiotensin system. Annu. Rev. Physiol. 40:1978;377-410.
2. Phillips M.I., Speakman E.A., Kimura B. Concentrations of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul. Pept. 43:1993;1-20.
3. Paul M., Wagner J., Dzau V.J. Gene expression of the renin-angiotensin system in human tissues: quantitative analysis by the polymerase chain reaction. J. Clin. Invest. 91:1993;2058-2064.
4. Timmermans P.B., Wong P.C., Chiu A.T.et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:1993;205-251.
5. Morgan L., Pipkin F.B., Kalsheker N. Angiotensinogen: molecular biology, biochemistry and physiology. Int. J. Biochem. Cell Biol. 28:1996;1211-1222.
6. Cassis L.A., Saye J.A., Peach M.J. Location and regulation of rat angiotensinogen messenger RNA. Hypertension. 11:1988;591-596.
7. Jones B.H., Standridge M.K., Taylor J.W., Moustaïd N. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am. J. Physiol. 273:1997;R236-R242.
8. Crandall D.L., Gordon G., Herzlinger H.E.et al. Transforming growth factor alpha and atrial natriuretic peptide in white adipose tissue depots in rats. Eur. J. Clin. Invest. 22:1992;676-680.
9. Jonsson J.R., Game P.A., Head R.J., Frewin D.B. The expression and localization of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood. 3:1994;72-75.
10. Crandall D.L., Herzlinger H.E., Saunders B.D., Armellino D.C., Kral J.G. Distribution of angiotensin II receptors in rat and human adipocytes. J. Lipid Res. 35:1994;1378-1385.
11. Ne'grel R., Gaillard D., Ailhaud G. Prostacyclin as a potent effector of adipose-cell differentiation. Biochem. J. 257:1989;399-405.
12. Darimont C., Vassaux G., Ailhaud G., Ne'grel R. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology. 135:1994;2030-2036.
13. Jones B.H., Standridge M.K., Moustaïd N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology. 138:1997;1512-1519.
14. Urata H., Healy B., Stewart R.W., Bumpus F.M., Husain A. Angiotensin II-forming pathways in normal and failing human hearts. Circ. Res. 66:1990;883-890.
15. Dzau V.J. Cell biology and genetics of angiotensin in cardiovascular disease. J. Hypertens., Suppl. 12:1994;S3-S10.
16. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme concentrations. J. Clin. Invest. 86:1990;1343-1346.
17. Tiret L., Rigat B., Visvikis S.et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE concentrations. Am. J. Hum. Genet. 51:1992;197-205.
18. Samani N.J., Thompson J.R., O'Toole L., Channer K., Woods K.L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 94:1996;708-712.
19. Carluccio M., Soccio M., De Caterina R. Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system. Eur. J. Clin. Investig. 31:2001;476-488.
20. Um J.Y., Kim H.J., Choi T.J., Jin C.S., Park S.T., Lee K.C.et al. Polymorphism of the angiotensin-converting enzyme gene in patients with cerebral infarction in Koreans. J. Mol. Neurosci. 17(3):2001;279-283.
21. Ferrannini E., Seghieri G., Muscelli E. Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition. J. Cardiovasc. Pharmacol. 24:1994;S61-S69.
22. Ambrosioni E., Bacchelli S., Degli Esposti D., Borghi C. ACE-inhibitors and atherosclerosis. Eur. J. Epidemiol. 8:1992;129-133.
23. Hennes M.M., O'Shaughnessy I.M., Kelly T.M., LaBelle P., Egan B.M., Kissebah A.H. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension. 28:1996;120-126.
24. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
25. Evans A.E., Poirier O., Kee F.et al. Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q. J. Med. 87:1994;211-214.
26. Bouchard C., Pérusse L., Leblac C., Tremblay A., Theriault G. Inheritance of the amount and distribution of human body fat. Int. J. Obes. 12:1998;205-215.
27. Faloia E., Camilloni M.A., Giacchetti G., Mantero F. Adipose tissue as an endocrine organ? A review of some recent data. Eat. Weight Disord. 5:2000;116-123.
28. Cooper R., McFarlane-Anderson N., Bennett F.I.et al. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J. Hum. Hypertens. 11:1997;107-111.
29. Thomas G.N., Tomlinson B., Chan J.C., Sanderson J.E., Cockram C.S., Critchley J.A. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of the ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care. 24:2001;356-361.
30. Katsuya T., Horiuchi M., Chen Y.D.et al. Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 15:1995;779-782.
31. Nagi D.K., Foy C.A., Mohamed-Ali V., Yudkin J.S., Grant P.J., Knowler W.C. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE concentrations, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism. 47:1998;622-626.
32. Hagberg J.M., Ferrell R.E., Dengel D.R., Wilund K.R. Exercise training-induced blood pressure and plasma lipid improvements in hypertensives may be genotype dependent. Hypertension. 34:1999;18-23.